Pulmonology News

Although vaccines have reduced the burden of pneumococcal disease, pneumonia due to Streptococcus pneumoniae and invasive pneumococcal disease remains prevalent.

Dupilumab led to improvement and was safe in adults with moderate to severe COPD and type 2 inflammation at week 52, according to a pooled analysis of BOREAS and NOTUS presented at the European Respiratory Society International Congress.

In young adults with normal spirometry, e-cigarette users and tobacco smokers had similar poorer exercise capacity vs. never vapers/smokers, according to a presentation at the European Respiratory Society International Congress.

The FDA has granted rare pediatric disease designation to Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile dermatomyositis, Cartesian Therapeutics announced in a press release.

Ivonescimab significantly improved PFS compared with pembrolizumab as first-line treatment of PD-L1-positive advanced non-small cell lung cancer, according to results of the HARMONi-2 trial.

Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.

Even one or two cigarettes a day before or during pregnancy can increase the risk for several health complications in newborns, study results published in the Journal of Epidemiology & Community Health showed.

Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers persist, according to survey results.

One important investment vehicle to understand when working toward slow and steady growth is the index fund.

Pediatric patients with community-acquired pneumonia spent less time in the hospital and receiving IV antibiotics when visited by a medical clown, according to a presentation at the European Respiratory Society International Congress.